Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novavax, Inc. - Common Stock (NQ: NVAX )

8.280 -0.190 (-2.24%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,060,306
Open 8.440
Bid (Size) 8.260 (65)
Ask (Size) 8.300 (19)
Prev. Close 8.470
Today's Range 8.190 - 8.669
52wk Range 3.532 - 23.86
Shares Outstanding 74,484,166
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Are You Ready To Trade Biotech Stocks At The Cusp Of A Bear Market?
It’s not a bear market for biotech yet it just feels that way because recent trends are down and healthcare stocks are not a stabilizing force. 
Via Talk Markets
Topics ETFs Stocks / Equities
Peering Into Novavax's Recent Short Interest
Via Benzinga

Performance

YTD
+64.61%
+64.61%
1 Month
-3.94%
-3.94%
3 Month
-37.74%
-37.74%
6 Month
-34.60%
-34.60%
1 Year
+68.64%
+68.64%

More News

Read More
Jim Cramer Is 'Not A Fan' Of Novavax, Says This Tech Stock Is 'Expensive'
Via Benzinga
Deal Dispatch: Ubisoft In Buyout Talks, Dental Supplier Explores Sale, Beloved Drive-Through Goes Bankrupt
Via Benzinga
Topics Supply Chain
Exposures Supply Chain
Earnings Scheduled For November 12, 2024
Via Benzinga
Earnings Outlook For Novavax
Via Benzinga
Looking Into Novavax's Recent Short Interest
Via Benzinga
How Is The Market Feeling About Novavax?
Via Benzinga
2 Beaten-Down "Pandemic Stocks" to Consider for Contrarian Investors
Via The Motley Fool
Wegovy Maker Novo Nordisk To Buy Novavax's Czech Republic Manufacturing Facility For $200 Million
Via Benzinga
Is Biotech’s Bull Run Over? Examining Election Impacts
Via MarketBeat
Topics ETFs Government
Exposures Political
Powell Speaks The Truth - Market Does Not Like It, Consternation About Kennedy, Gaetz, And Hegseth
Via Benzinga
Pfizer, Moderna, Novavax Take A Beating After Trump Taps Kennedy To Head Up HHS
Via Investor's Business Daily
Topics Government
Exposures Political
WHO Calls Vaccines 'Absolutely Critical' As Trump's Appointment Of RFK Jr Pulls Pzifer, Moderna Stocks Downhill
Via Benzinga
Topics Government
Exposures Political
US Stocks Likely To Open In Red After Jerome Powell Says No Need To Be 'In A Hurry' On Rate Cuts: Tesla, TSMC And Domino's In Focus
Via Benzinga
Topics Economy
Exposures Economy Interest Rates
Trump Taps RFK Jr. For Health Secretary Role, Sends 5 Vaccine Stocks Lower
Via Benzinga
Topics Government
Exposures Political
Novavax Lowers 2024 Forecast Despite Q3 Revenue Beat, Stock Falls
Via Benzinga
Exposures Product Safety
FDA Gives Green Signal To Novavax's COVID-19-Influenza Combo Vaccine Late-Stage Trial
Via Benzinga
Exposures Product Safety
Smaller Cap Biotechs Are In Season: How Are We Doing?
Via Talk Markets
Why Is COVID-19 Vaccine Maker Novavax Stock Trading Lower On Wednesday?
Via Benzinga
Exposures COVID-19
NVAX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Novavax, Inc. and Encourages Investors to Contact the Firm
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
3 Spooky Signs That You're About to Lose Your Money on a Healthcare Stock Investment
Via The Motley Fool
This Vaccine Stock Just Dropped by 20%: Should You Buy the Dip?
Via The Motley Fool
NVAX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Into Novavax, Inc. and Encourages Investors to Contact the Firm
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
How Bad Is This News for Novavax?
Via The Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.